Abstracts

IN VIVO EVALUATION OF LONG-ACTING BIODEGRADABLE EMTRICITABINE IMPLANTS

Long-acting (LA) antiretroviral interventions hold promise to revolutionise HIV therapy and prevention and mitigate key concerns regarding adherence to oral medications. The current study investigated a biodegradable subcutaneous implant derived from a polymer formed entirely from an emtricitabine (FTC) prodrug (POP implant). For in vitro studies, POP implants were incubated in 1 mL of phosphate…

PHARMACOGENOMIC TESTING PROVIDES INSIGHT AND ENHANCES MEDICATION MANAGEMENT IN PLWHIV

Pharmacogenomics is the area of individualized medicine focused on genetic polymorphisms in drug-metabolizing enzymes, transporters, receptors, and drug targets that explain inter-individual variation in drug efficacy and toxicity. Single gene assessment of HLA-B*57:01 prior to abacavir use is well-established in the care of PLWHIV. However, pharmacogenomic panel testing (assessing multiple genes rather than a single…

A NOVEL COVID-19 CURE STRATEGY: HIJACKING SARS-CoV-2 RNA-DEPENDENT RNA POLYMERASE

SARS-CoV-2 is a single-stranded positive-sense RNA virus that utilizes a negative-sense subgenomic (sg)RNA intermediates for viral protein synthesis. We developed a synthetic RNA (‘hijack RNA’) that is designed to be recognized by SARS-CoV-2 RNA-dependent RNA polymerase (RdRp). Upon recognition, hijack RNA is transcribed into diphtheria toxin fragment A (DT-A), to induce death specifically in infected…

RATIONALLY DESIGNED ACE2-DERIVED PEPTIDES INHIBIT SARS-CoV-2

Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 is a novel and highly pathogenic coronavirus and is the causative agent of the coronavirus disease 2019 (COVID-19). The high morbidity and mortality associated with COVID-19 and the lack of an approved drug or vaccine for SARS-CoV-2 underscores the urgent need for developing effective antiviral therapies. Therapeutics that target…

IN SILICO PREDICTION OF MONTHLY BICTEGRAVIR MICRONEEDLE ARRAY PATCHES

Microneedle array patches (MAPs) comprise of multiple micron-scale needles that can provide painless administration of long-acting nanoformulated drug, producing effective drug plasma concentrations over extended periods of time. The current study used physiologically-based pharmacokinetic (PBPK) modelling to predict optimal dosing strategies of bictegravir (BIC) via MAP administration. A whole-body PBPK model was designed in Simbiology…